In our study, significant differential methylation of RASSF1 between FTC-Classic and FTC-Hurthle tumor suggests that DNA methylation markers may be useful in discriminating among thyroid cancer subtypes. This evidence concerns the gene RASSF1 and thyroid gland carcinoma.